“Understanding these factors is crucial for designing preventive programs and mental health resource planning during the rapidly evolving COVID-19 outbreak,” said the paper’s lead author Tazeen Jafar, a professor in the Health Services and Systems Research Programme at Duke-NUS who led the study.
Showing posts with label Covid-19 Healthcare. Show all posts
Showing posts with label Covid-19 Healthcare. Show all posts
Thursday, February 18, 2021
EU orders additional 200 million Pfizer / BioNTech vaccines
Those doses will come in addition to 300 million previously ordered by the Commission, BioNTech clarified in a press release. The doses are “expected to be delivered in 2021, with an estimated 75 million to be supplied in the second quarter,” according to BioNTech.
EU prepares for increased threat of virus variants – is it enough?
The new European bio-defence preparedness plan against COVID-19 variants, called “HERA Incubator”, will work with researchers, biotech companies, manufacturers and public authorities in the EU and globally to detect new variants, provide incentives to develop new and adapted vaccines, speed up the approval process for these vaccines, and ensure scaling up of manufacturing capacities.
Subscribe to:
Posts (Atom)